Cantor Fitzgerald, L. P. Eli Lilly & CO Transaction History

Cantor Fitzgerald, L. P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $354,461 - $444,520	489 Added 38.78%	1,750 $1.58 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $270,043 - $361,279	-456 Reduced 26.56%	1,261 $981,000
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $164,384 - $193,787	313 Added 22.29%	1,717 $1 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $223,772 - $299,209	638 Added 83.29%	1,404 $658,000
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $237,942 - $279,452	766 New	766 $263,000
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $280,959 - $329,888	-1,008 Reduced 46.34%	1,167 $378,000
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $510,450 - $634,360	2,175 New	2,175 $623,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.